NCT01678352
- Conditions
- Glioma, Hemic and Lymphatic Diseases, High Risk WHO Grade II Glioma, +15 more
- Locations
-
- University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States
Clinical trial condition
Recurrent/Post-Chemotherapy WHO Grade II Glioma
Explore clinical trials studying Recurrent/Post-Chemotherapy WHO Grade II Glioma. Study availability and eligibility vary by location and protocol.
1 public trial
0 recruiting studies